Seres Therapeutics MCRB
NASDAQ MCRB
$2.08 -0.22 (-9.57%)
As of: Oct 22, 2026 · 10:37 AM EDT

Seres Therapeutics (MCRB) Preferred Stock Liabilities (2014)

Updated

Seres Therapeutics' Preferred Stock Liabilities came in at $136.08 million for Q4 2014.

Analysis

Seres Therapeutics (MCRB) Preferred Stock Liabilities (2014) Analysis & Trends

  • Going back by year, Preferred Stock Liabilities was $11.58 million in FY2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,163.39 Bn 1,131.97 Bn 19.71 Bn -
2 Johnson & Johnson 634.39 Bn 552.91 Bn 17.26 Bn -
3 AbbVie 502.68 Bn 475.79 Bn 12.70 Bn -
4 Merck 377.37 Bn 331.74 Bn 12.21 Bn -
5 Novartis Ag 303.41 Bn 267.40 Bn 11.24 Bn -
6 Astrazeneca 266.55 Bn 240.24 Bn 12.86 Bn -
7 Amgen 240.56 Bn 195.96 Bn 7.24 Bn -
8 Gilead Sciences 193.19 Bn 167.38 Bn 6.22 Bn -
9 Pfizer 172.14 Bn 118.78 Bn 10.94 Bn -
10 Seres Therapeutics 20.19 Mn -118.64 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 136.08 Mn
API Access

Seres Therapeutics Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=MCRB&period=max&api_key=YOUR_API_KEY